Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Cash from Financing Activities (2016 - 2022)

Historic Cash from Financing Activities for International Stem Cell (ISCO) over the last 13 years, with Q1 2022 value amounting to $250000.0.

  • International Stem Cell's Cash from Financing Activities fell 6966.02% to $250000.0 in Q1 2022 from the same period last year, while for Dec 2022 it was $250000.0, marking a year-over-year decrease of 6966.02%. This contributed to the annual value of -$200000.0 for FY2024, which is N/A changed from last year.
  • Per International Stem Cell's latest filing, its Cash from Financing Activities stood at $250000.0 for Q1 2022, which was down 6966.02% from $824000.0 recorded in Q1 2021.
  • In the past 5 years, International Stem Cell's Cash from Financing Activities ranged from a high of $1.4 million in Q3 2018 and a low of -$53000.0 during Q1 2019
  • In the last 4 years, International Stem Cell's Cash from Financing Activities had a median value of $500000.0 in 2019 and averaged $543111.1.
  • Over the last 5 years, International Stem Cell's Cash from Financing Activities had its largest YoY gain of 406666.67% in 2019, and its largest YoY loss of 11352.04% in 2019.
  • Over the past 4 years, International Stem Cell's Cash from Financing Activities (Quarter) stood at $12000.0 in 2018, then soared by 4066.67% to $500000.0 in 2019, then soared by 64.8% to $824000.0 in 2021, then crashed by 69.66% to $250000.0 in 2022.
  • Its Cash from Financing Activities was $250000.0 in Q1 2022, compared to $824000.0 in Q1 2021 and $500000.0 in Q4 2019.